David Chu

David Chu

Company: Arcutis Biotherapeutics

Job title: Vice President, Clinical Development

Seminars:

Intentional & Tailored Design of Topical Therapy for Inflammatory Skin Diseases 3:00 pm

Appropriate target identification can facilitate clinically meaningful efficacy and a suitable MoA for dermatologic treatment Clinical expertise can inform optimal vehicle development most suited to patients’ needs Thoughtful development strategy can reflect the goal of long-term disease control in patients with chronic inflammatory skin diseaseRead more

day: Conference Day One

Panel Discussion: Monoclonals, Topicals, Orals, Targets, Mild Disease & More – Where Are the Industry’s Priorities to Develop Safe Therapies with Superior Efficacy? 9:30 am

With a rich pipeline of drugs targeting various inflammatory mechanisms, for different indications and leveraging different approaches, what will be the next blockbuster drug to reach the market? How are safety concerns around systemics and efficacy challenges around topicals being addressed, amidst regulatory and reimbursement environments? Faced with varying challenges to demonstrating clinical superiority and…Read more

day: Conference Day One

A Hanson Wade Group Company

© Copyright 2024 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Eastcastle House, 27/28 Eastcastle Street, London, W1W 8DH.